查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1972758

聚碸透析器市場：依透析器類型、滅菌方法、膜結構、通路和最終用戶分類－2026-2032年全球預測

Polysulfone Dialyzer Market by Dialyzer Type, Sterilization Method, Membrane Configuration, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，聚碸透析器市場價值將達到 13.9 億美元，到 2026 年將成長至 15.7 億美元，到 2032 年將達到 32.6 億美元，年複合成長率為 12.84%。

主要市場統計數據
基準年 2025 13.9億美元
預計年份：2026年 15.7億美元
預測年份 2032 32.6億美元
複合年成長率 (%) 12.84%

本文重點介紹聚碸透析器的基本特性與市場相關性，整合材料優勢、臨床需求與採購重點，供決策者參考。

聚碸透析器是材料科學、臨床實踐和醫療保健系統採購的交叉領域。過去十年，這些透析器憑藉其生物相容性、機械強度和可靠的清除性能，已成為體外治療的必備工具。本文概述了聚碸為何仍然是首選的膜材料，產品在效率和通量分佈方面的差異化趨勢，並提供了一個討論框架，闡述了相關人員（從臨床醫生到供應鏈經理）在評估透析器產品組合時，為何必須同時考慮臨床結果和物流實際情況。

臨床創新、醫療服務模式的轉變以及不斷發展的供應鏈正在全面重塑透析機產業的競爭格局和產品設計重點。

腎臟替代治療設備領域正經歷變革性的轉變，這主要得益於臨床創新、醫療服務模式的轉變以及供應鏈的重組。膜工程技術的進步催生了新型透析器，這些透析器能夠最佳化溶質清除並最大限度地減少發炎反應，迫使臨床醫生改進處方模式，並將更精細的設備選擇納入個別化的治療方案中。同時，合適的透析治療正加速從醫療機構轉移到居家照護，這促使人們對兼具易用性和穩定性能的設備產生了濃厚的興趣。反過來，這也對製造商提出了新的產品設計和培訓需求。

本檢驗了2025 年美國實施的貿易政策變化如何影響整個聚碸透析器價值鏈的成本結構、籌資策略和購買行為。

美國於2025年實施的關稅措施和貿易政策變化對聚碸透析器生態系統產生了累積影響，改變了投入成本、採購決策和下游採購慣例。依賴國際供應鏈取得聚碸原料、組件和滅菌服務的製造商面臨更高的到岸成本和供應商前置作業時間更大的波動，迫使他們重新評估庫存策略和合約條款。因此，一些製造商正在加快近岸外包投資，並探索替代供應商契約，以恢復利潤穩定性並降低受貿易政策週期的影響。

基於細分市場的洞察，將透析器產品特性、滅菌方法、通路和最終用戶需求與市場定位中的實際差異化因素聯繫起來。

對細分市場績效的詳細分析表明，當產品按設備特性、終端用戶環境、分銷方式、滅菌方法和膜結構進行分類時，可以清楚地找到價值創造的路徑。根據透析器類型，市場環境可分為傳統透析器、高效率透析器和高通量透析器。傳統透析器可細分為低通量和中通量兩種類型，高效透析器可細分為標準效率和超高效兩種類型，高通量透析器可細分為標準高通量和超高通量兩種類型。這些區分至關重要，因為它們決定了每種透析器在醫療機構治療方案組合中的定位，而這取決於臨床通訊協定、治療時間長度和溶質清除目標。

該分析整合了美洲、歐洲、中東和非洲以及亞太地區的商業性、監管和基礎設施趨勢，有助於制定針對每個市場的市場進入和擴大策略。

區域趨勢持續對產品策略、監管合規和商業性執行產生重大影響。在美洲，成熟的臨床通訊協定、整合的採購集團以及私人保險公司的積極參與，共同創造了一個環境，​​在這種環境下，產品差異化、循證實踐和服務水平保障是獲得長期合約的關鍵。該地區的醫療服務提供者重視可驗證的臨床結果和生命週期成本的透明度，能夠提供強力的上市後監測和快速現場支援的供應商更具優勢。

以製造規模、材​​料創新和綜合服務為中心的競爭與合作型企業策略將決定企業的長期商業性韌性。

材料科學、生產規模化、監管靈活性和綜合服務交付能力正在重新定義主要企業與新興企業之間的競爭格局。擁有深厚生產基礎的老牌製造商在單位成本控制和分銷網路覆蓋方面保持優勢，而專業技術公司則透過膜創新、塗層化學和專有滅菌改造技術脫穎而出，從而帶來臨床或物流方面的優勢。新參與企業通常會瞄準特定的臨床應用情境和護理環境，例如家庭透析和輔助生活項目。在這些領域，模組化產品設計和簡化的使用者介面可以減輕培訓負擔，促進產品推廣應用。

為製造商和供應商制定可操作且優先的行動方案，以協調產品創新、供應鏈韌性和通路策略，從而建立永續的競爭優勢。

產業領導者應採取多管齊下的策略，整合產品創新、供應鏈韌性和上市時間柔軟性。首先，優先投資於符合人體工學的薄膜和設備設計，以直接改善臨床醫師的工作流程，提升病患在醫療機構和居家照護環境中的舒適度，進而降低推廣應用的門檻。其次，實現採購和滅菌夥伴關係關係的多元化，以建立冗餘機制，降低政策主導的成本衝擊風險。最後，建立商業性可行性的區域性製造或合約製造安排，以縮短前置作業時間，並提高應對力。

我們採用透明的基於三角測量的調查方法，結合對臨床醫生的訪談、監管和技術審查以及情境分析，以確保研究結果的穩健性和可重複性。

本研究採用系統性的調查方法，整合一手和二手訊息，強調檢驗、三角測量和可重複性。一手資訊包括對關鍵地區臨床醫生、採購經理和分銷合作夥伴的結構化訪談，以及對構成技術聲明基礎的監管申報文件、滅菌通訊協定和生產流程文件的實證審查。二級資訊來源包括對膜性能的同行評審文獻、關於透析最佳實踐的公共指南以及與貿易和醫療設備法規相關的政策文件的分析，並闡述其戰略意義。

對關鍵策略結論的簡要總結，清楚地表明了為什麼產品、供應鏈和服務一體化的方法對於在不斷發展的透析器市場取得成功至關重要。

總之，聚碸透析器憑藉其卓越的臨床性能和便利的生產流程，仍然是透析治療的基礎。市場格局正受到多種因素的共同影響而重塑，包括對最佳化清除率和生物相容性的臨床需求、居家護理的興起、分銷和滅菌方法的進步，以及政策主導的供應鏈調整。那些將產品創新與實證醫學結果相結合、投資於供應鏈韌性並製定針對特定終端用戶環境的分銷和培訓策略的企業，將在不斷變化的市場環境中蓬勃發展。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：聚碸透析器市場（依透析器類型分類）

  • 傳統透析器
    • 低通量透析器
    • 中通量透析器
  • 高效透析器
    • 標準效率透析器
    • 超高效透析器
  • 高通量透析器
    • 標準高通量透析器
    • 超高通量透析器

第9章：聚碸透析器市場依滅菌方法分類

  • 環氧乙烷滅菌
  • 伽瑪射線滅菌
    • 高劑量伽瑪射線滅菌
    • 低劑量伽馬射線滅菌
  • 蒸氣滅菌

第10章：按膜成分分類的聚碸透析器市場

  • 平板
    • 板框
    • 螺旋纏繞式
  • 中空纖維型
    • 多流明
    • 單流明

第11章：聚碸透析器市場：依分銷管道分類

  • 直銷
  • 線上管道
  • 第三方經銷商
    • 醫療設備供應商
    • 零售藥房

第12章聚碸透析器市場：依最終用戶分類

  • 透析中心
  • 居家照護環境
    • 居家護理支援服務
    • 自我管理
  • 醫院

第13章：聚碸透析器市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章聚碸透析器市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：聚碸透析器市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國聚碸透析器市場

第17章：中國聚碸透析器市場

第18章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Jafron Biomedical Co., Ltd.
  • JMS Co., Ltd.
  • MEDICA SpA
  • Nipro Corporation
  • Nipro Corporation
  • Poly Medicure Limited
  • Terumo Corporation
  • Toray Industries, Inc.
Product Code: MRR-9A6A6F297DBA

The Polysulfone Dialyzer Market was valued at USD 1.39 billion in 2025 and is projected to grow to USD 1.57 billion in 2026, with a CAGR of 12.84%, reaching USD 3.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.39 billion
Estimated Year [2026] USD 1.57 billion
Forecast Year [2032] USD 3.26 billion
CAGR (%) 12.84%

A focused orientation to polysulfone dialyzer fundamentals and market relevance that synthesizes material strengths, clinical needs, and procurement priorities for decision-makers

Polysulfone dialyzers sit at the intersection of material science, clinical practice, and health system procurement. Over the last decade, their combination of biocompatibility, mechanical strength, and reliable clearance characteristics has established them as a mainstay in extracorporeal therapy. This introduction frames the conversation by outlining why polysulfone remains a preferred membrane material, how product differentiation is occurring across efficiency and flux profiles, and why stakeholders from clinicians to supply chain managers must consider both clinical outcomes and logistical realities when evaluating dialyzer portfolios.

Transitioning from material properties to market implications, the subsequent analysis situates polysulfone dialyzers within contemporary trends: an aging patient population with rising chronic kidney disease prevalence, pressure to shift suitable patients to home-based therapies, and heightened scrutiny of device lifecycle costs. These forces shape procurement strategy and clinical adoption curves. Consequently, a rigorous understanding of device types, sterilization methods, membrane configurations, and distribution pathways is essential for decision-makers seeking to balance patient outcomes, regulatory compliance, and financial sustainability.

How clinical innovation, care delivery migration, and supply chain evolution are collectively reshaping competitive dynamics and product design priorities in the dialyzer field

The landscape for renal replacement devices is undergoing transformative shifts driven by clinical innovation, care-delivery migration, and supply chain reengineering. Advances in membrane engineering have produced dialyzers that optimize solute clearance while minimizing inflammatory response, prompting clinicians to refine prescription patterns and integrate more nuanced device selection into individualized care plans. Simultaneously, the migration of suitable dialysis therapies from in-center units to home care settings has accelerated interest in devices that combine ease of use with consistent performance, creating new product design and training imperatives for manufacturers.

On the supply side, distribution and sterilization modalities are adapting to meet demand for rapid replenishment and regulatory traceability. Online and direct-to-provider channels are gaining traction alongside traditional third-party distributors, while sterilization choices-ranging from ethylene oxide to gamma and steam-affect inventory handling, shelf-life considerations, and cost structures. Taken together, these shifts are reshaping competitive dynamics: companies that integrate clinical evidence, scalable manufacturing, and responsive channel strategies are positioned to capture differentiated value across care settings.

An examination of how 2025 trade policy shifts in the United States have altered cost structures, sourcing strategies, and procurement behavior across the polysulfone dialyzer value chain

The imposition of tariffs and trade policy changes in the United States during 2025 has exerted a cumulative effect on the polysulfone dialyzer ecosystem by altering input costs, sourcing decisions, and downstream procurement practices. Manufacturers that rely on international supply chains for raw polysulfone resin, components, or sterilization services have confronted increased landed costs and greater volatility in supplier lead times, which in turn has forced reassessment of inventory strategies and contract terms. As a result, some producers accelerated nearshoring investments or sought alternative vendor arrangements to restore margin stability and reduce exposure to trade-policy cycles.

For health systems and distributors, the tariff environment heightened attention to total landed cost and contract flexibility. Purchasing teams extended horizon planning for capital and consumable procurement, prioritized multi-supplier contracts, and emphasized supplier transparency around cost drivers. At the same time, sterilization workflows experienced indirect impacts: differential tariff effects on sterilization equipment and consumables influenced decisions between ethylene oxide, gamma, and steam processes based on availability, turnaround time, and regulatory compliance costs. Longer term, these policy shifts prompted manufacturers to re-evaluate pricing strategies, invest in supply-chain resilience, and accelerate product differentiation efforts that could justify premium positioning despite upward pressure on cost structures.

Segmentation-driven insights that map dialyzer product attributes, sterilization choices, distribution channels, and end-user needs into actionable differentiators for market positioning

A nuanced reading of segment performance reveals distinct pathways for value creation when products are parsed by device characteristics, end-user environment, distribution mode, sterilization approach, and membrane architecture. Based on dialyzer type, the landscape spans Conventional Dialyzers, High-Efficiency Dialyzers, and High-Flux Dialyzers, with Conventional offerings differentiated further into Low-Flux and Medium-Flux variants, High-Efficiency split between Standard and Ultra Efficiency approaches, and High-Flux categorized into Standard High-Flux and Super High-Flux tiers. These distinctions matter because clinical protocols, session duration, and solute removal objectives determine where each type fits within a provider's therapy mix.

End-user segmentation clarifies where adoption pressure is concentrated: dialysis centers, home care settings, and hospitals each exhibit different operational constraints and purchasing models, and the home setting itself bifurcates between assisted home care and self-care models that carry divergent device usability and training requirements. Distribution pathways influence time-to-clinic and service expectations, where direct sales, online channels, and third-party distributors-further segmented into medical equipment suppliers and retail pharmacy networks-play complementary roles in market reach and post-sale support. Sterilization method considerations, including ethylene oxide, gamma (with high dose and low dose distinctions), and steam processes, affect inventory turnover, regulatory documentation, and shelf-life decisions. Finally, membrane configuration-flat sheet versus hollow fiber, with further splits across plate and frame, spiral wound, multi lumen, and single lumen designs-drives manufacturing complexity and clinical handling procedures. Understanding these interlocking segments enables companies to tailor product design, training programs, and service models to the operational realities of each channel and care setting.

A regional synthesis of commercial, regulatory, and infrastructure dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that informs tailored market entry and scaling strategies

Regional dynamics continue to exert a strong influence on product strategy, regulatory compliance, and commercial execution. In the Americas, mature clinical protocols, consolidated purchasing groups, and active private payor participation create an environment where product differentiation, evidence generation, and service-level guarantees are critical to securing long-term contracts. Providers in this region place a premium on demonstrable clinical outcomes and lifecycle cost transparency, which favors suppliers that can provide robust post-market surveillance and responsive field support.

Europe, the Middle East & Africa present a heterogeneous mix of reimbursement models, regulatory timelines, and infrastructure maturity. In several European markets, centralized procurement and stringent regulatory pathways reward clinical data and cost-effectiveness narratives, whereas emerging markets within the broader region emphasize affordability and supply-chain reliability. Across these territories, varying access to sterilization infrastructure and distribution networks shapes localization strategies. In the Asia-Pacific region, diverse market maturity ranges from advanced clinical adoption in some urban centers to rapidly expanding dialysis access in other areas. Manufacturers operating here must reconcile the need for scalable, cost-efficient products with localized training and service frameworks, while also navigating variable regulatory regimes and import policies that influence commercial rollout timing.

Competitive and collaborative company strategies centered on manufacturing scale, materials innovation, and integrated services that determine long-term commercial resilience

Competitive dynamics among leading firms and emerging players are being redefined by capabilities in materials science, manufacturing scale-up, regulatory agility, and integrated service offerings. Established producers with deep manufacturing footprints maintain advantages in unit-cost management and distribution network reach, while specialist technology players differentiate through membrane innovation, coating chemistries, or proprietary sterilization adaptations that deliver clinical or logistical benefits. New entrants often target niche clinical use-cases or care settings-such as home dialysis or assisted-care programs-where modular product designs and simplified user interfaces reduce training burdens and enhance adoption.

Partnerships between manufacturers, sterilization service providers, and distributors are becoming increasingly strategic; collaborations that align product development with sterilization workflows and distribution logistics yield faster time-to-clinic and improved shelf-life management. In addition, value-added services-such as remote device monitoring, clinician training programs, and bundled consumable offerings-are shaping account-level competition. Firms that invest in demonstrating real-world outcomes and that can support institutional purchasers with credible implementation roadmaps are better positioned to secure long-term contracts and to defend against price-centric competition.

Practical, prioritized actions for manufacturers and providers to align product innovation, supply-chain resilience, and channel strategy for durable competitive advantage

Industry leaders should adopt a multifaceted approach that aligns product innovation with supply-chain resilience and go-to-market versatility. First, prioritize investments in membrane and device ergonomics that directly address clinician workflow and patient comfort in both in-center and home-care environments, thereby reducing adoption friction. Second, diversify sourcing and sterilization partnerships to build redundancy and to mitigate exposure to policy-driven cost shocks; cultivate regional manufacturing or tolling arrangements where commercially sensible to shorten lead times and improve responsiveness.

Third, strengthen commercial value propositions by coupling product performance evidence with service-level commitments, such as training curricula for assisted-home models and rapid-response logistics for hospital accounts. Fourth, rationalize distribution strategies to balance direct relationships with high-volume purchasers and digital channels that reach smaller providers and self-care consumers. Finally, embed regulatory intelligence and post-market evidence generation into product roadmaps, ensuring that clinical efficacy, safety reporting, and lifecycle management are prioritized in tandem with commercial milestones. Taken together, these steps create defensible positions and enhance the ability to capture value across diverse segments and regions.

A transparent, triangulated research methodology combining clinician interviews, regulatory and technical reviews, and scenario analysis to ensure robust and reproducible insights

This research synthesis blends primary and secondary intelligence with a disciplined methodology that emphasizes validation, triangulation, and reproducibility. Primary inputs included structured interviews with clinicians, procurement leaders, and distribution partners across major regions, combined with empirical reviews of regulatory filings, sterilization protocols, and manufacturing process documentation to ground technical assertions. Secondary inputs were derived from peer-reviewed literature on membrane performance, published guidance on dialysis best practices, and public policy documents related to trade and medical device regulation to contextualize strategic implications.

Analytical methods involved cross-segment triangulation to ensure that insights reflected consistent patterns across device types, end-user environments, and distribution channels. Scenario analysis was applied to assess operational responses to supply-chain disruptions and trade-policy changes, while sensitivity checks were used to validate qualitative conclusions against alternative assumptions. Wherever possible, evidence hierarchies were applied so that clinical claims cited higher-quality sources and operational observations drew upon multiple independent confirmations. This approach provides a defensible foundation for the recommendations and strategic observations presented herein.

A concise synthesis of key strategic conclusions highlighting why integrated product, supply-chain, and service approaches determine success in the evolving dialyzer market

In conclusion, polysulfone dialyzers remain a cornerstone of dialysis therapy because they harmonize proven clinical performance with manufacturing practicality. The market landscape is being reshaped by a confluence of forces: clinical demand for optimized clearance and biocompatibility, the migration of care into home environments, evolving distribution and sterilization practices, and policy-driven supply-chain adjustments. Organizations that align product innovation with evidence-based outcomes, invest in supply-chain resilience, and tailor distribution and training strategies for specific end-user contexts will be best positioned to win in this evolving environment.

As stakeholders evaluate future investments, the focus should be on integrated approaches that combine material and device improvements with service models that simplify adoption. In an environment where regulatory scrutiny, procurement expectations, and clinical protocols are continuously evolving, the ability to translate technical advantages into operational and financial value will determine sustained commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Polysulfone Dialyzer Market, by Dialyzer Type

  • 8.1. Conventional Dialyzers
    • 8.1.1. Low-Flux Dialyzers
    • 8.1.2. Medium-Flux Dialyzers
  • 8.2. High-Efficiency Dialyzers
    • 8.2.1. Standard Efficiency Dialyzers
    • 8.2.2. Ultra Efficiency Dialyzers
  • 8.3. High-Flux Dialyzers
    • 8.3.1. Standard High-Flux Dialyzers
    • 8.3.2. Super High-Flux Dialyzers

9. Polysulfone Dialyzer Market, by Sterilization Method

  • 9.1. Ethylene Oxide Sterilized
  • 9.2. Gamma Sterilized
    • 9.2.1. High Dose Gamma
    • 9.2.2. Low Dose Gamma
  • 9.3. Steam Sterilized

10. Polysulfone Dialyzer Market, by Membrane Configuration

  • 10.1. Flat Sheet
    • 10.1.1. Plate And Frame
    • 10.1.2. Spiral Wound
  • 10.2. Hollow Fiber
    • 10.2.1. Multi Lumen
    • 10.2.2. Single Lumen

11. Polysulfone Dialyzer Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Channels
  • 11.3. Third-Party Distributors
    • 11.3.1. Medical Equipment Suppliers
    • 11.3.2. Retail Pharmacies

12. Polysulfone Dialyzer Market, by End User

  • 12.1. Dialysis Centers
  • 12.2. Home Care Settings
    • 12.2.1. Assisted Home Care
    • 12.2.2. Self-Care
  • 12.3. Hospitals

13. Polysulfone Dialyzer Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Polysulfone Dialyzer Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Polysulfone Dialyzer Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Polysulfone Dialyzer Market

17. China Polysulfone Dialyzer Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Asahi Kasei Medical Co., Ltd.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Baxter International Inc.
  • 18.8. Fresenius Medical Care AG & Co. KGaA
  • 18.9. Jafron Biomedical Co., Ltd.
  • 18.10. JMS Co., Ltd.
  • 18.11. MEDICA S.p.A.
  • 18.12. Nipro Corporation
  • 18.13. Nipro Corporation
  • 18.14. Poly Medicure Limited
  • 18.15. Terumo Corporation
  • 18.16. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POLYSULFONE DIALYZER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POLYSULFONE DIALYZER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDIUM-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ULTRA EFFICIENCY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STANDARD HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SUPER HIGH-FLUX DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ETHYLENE OXIDE STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HIGH DOSE GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY LOW DOSE GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY STEAM STERILIZED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY PLATE AND FRAME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SPIRAL WOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY MEDICAL EQUIPMENT SUPPLIERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY ASSISTED HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY SELF-CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GCC POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 237. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 238. GCC POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 239. GCC POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 240. GCC POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 241. GCC POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 242. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 243. GCC POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. GCC POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GCC POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 275. G7 POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. G7 POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 279. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 280. G7 POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 281. G7 POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 282. G7 POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 283. G7 POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 284. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 285. G7 POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 286. G7 POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 287. G7 POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. G7 POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 289. NATO POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. NATO POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 293. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 294. NATO POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 295. NATO POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 296. NATO POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 297. NATO POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 298. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 299. NATO POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. NATO POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 301. NATO POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. NATO POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL POLYSULFONE DIALYZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY DIALYZER TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY CONVENTIONAL DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-EFFICIENCY DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HIGH-FLUX DIALYZERS, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY GAMMA STERILIZED, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY MEMBRANE CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY FLAT SHEET, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HOLLOW FIBER, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES POLYSULFONE DIALYZER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA POLYSULFONE DIALYZER MARKET SIZE, 2018-2032 (USD MILLION)

TABLE 3